Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination ...

TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (“Psyence Biomed”) is excited to announce the completion of its merger (the “Business Combination”) with Newcourt Acquisition Corp ("Newcourt"), a

Related Keywords

United Kingdom ,Toronto ,Ontario ,Canada ,United States ,Australia ,Australian ,Canadian ,Commonwealth Of Australia ,American ,America ,Neil Maresky ,Psyence Biomed ,Newcourt Acquisition Corp ,Canadian Securities Exchange ,Psyence Group ,Nasdaq ,Linkedin ,Twitter ,Pty Ltd ,Instagram ,Psyence Group Inc ,Purpose Acquisition Company ,Psyence Biomedical Ltd ,Psyence Biomed Division ,Business Combination ,Note Financing ,Special Meeting ,Therapeutic Goods Administration ,North America ,Private Securities Litigation Reform Act ,North American ,Registration Statement ,Psyence Production ,Psyence Therapeutics ,Psyence Function ,Southern Africa ,Acquisition Corp ,Special Purpose Acquisition Company ,Region ,